The Claim
Creatine monohydrate supplementation at 20 grams per day for 8 weeks does not cause clinically significant changes in renal or metabolic safety markers in adults with Alzheimer's disease.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking 20 grams of creatine monohydrate daily for 8 weeks does not alter kidney or metabolic safety markers in adults with Alzheimer's disease.
See the scientific wording
Creatine monohydrate supplementation at 20 grams per day for 8 weeks does not cause clinically significant changes in renal or metabolic safety markers in adults with Alzheimer's disease, suggesting short-term safety in this population.
When someone takes creatine every day, their blood creatine levels go up, and the brain absorbs more of it to make more energy. The kidneys and liver do not get overloaded or damaged because the body naturally handles this extra creatine without changing how it processes waste or regulates blood chemicals.
What the research says
1 studyStudy: Creatine monohydrate pilot in Alzheimer's: Feasibility, brain creatine, and cognition
People with Alzheimer’s took 20 grams of creatine daily for 8 weeks, and almost everyone stuck with it without any reported problems — so it seems safe for short-term use, even though they didn’t specifically check kidney or liver tests.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.